Association between Thrombolysis In Myocardial Infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: Observations from the Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Antiplatelet and Antithrombotic Agents-Thrombolysis

American Heart Journal

Volumn 152, Issue 4, 2006, Pages 756-761

  Gibson, C Michael ^a,b,c   Kirtane, Ajay J ^c   Morrow, David A ^a,b   Palabrica, Theresa M ^d   Murphy, Sabina A ^a,b   Stone, Peter H ^a,b   Scirica, Benjamin M ^a,b   Jennings, Lisa K ^e   Herrmann, Howard C ^f   Cohen, David J ^c   McCabe, Carolyn H ^a,b   Braunwald, Eugene ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CLOPIDOGREL; CREATINE KINASE MB; ENOXAPARIN; EPTIFIBATIDE; HEPARIN; HIRULOG; PYRIDINE DERIVATIVE; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; DEATH; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HOLTER MONITORING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; MALE; MICROCIRCULATION; MIDDLE AGED; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; SYNDROME; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 33748776831     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.04.016     Document Type: Article

References (17)

1. van't Hof A.W.J., Liem A., Suryapranata H., et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 97 (1998) 2302-2306
2. Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105 (2002) 1909-1913
3. Stone G.W., Peterson M.A., Lansky A.J., et al. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 39 (2002) 591-597
4. Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101 (2000) 125-130
5. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 312 (1985) 932-936
6. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
7. Manginas A, Gatzov P, Chasikidis C, et al. Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method. Am J Cardiol 1999;83:1562-5, A7.
8. Stoel M.G., Zijlstra F., and Visser C.A. Frame count reserve. Circulation 107 (2003) 3034-3039
9. Wong G.C., Morrow D.A., Murphy S., et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction. Circulation 106 (2002) 202-207
10. Bolognese L., Ducci K., Angioli P., et al. Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes. Circulation 110 (2004) 1592-1597
11. Selvanayagam J.B., Porto I., Channon K., et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 111 (2005) 1027-1032
12. Choi J.W., Gibson C.M., Murphy S.A., et al. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction. Catheter Cardiovasc Interv 61 (2004) 472-476
13. Kern M.J. Coronary physiology revisited: practical insights from the cardiac catheterization laboratory. Circulation 101 (2000) 1344-1351
14. Dorge H., Neumann T., Behrends M., et al. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol 279 (2000) H2587-H2592
15. Cobb F.R., Bache R.J., Rivas F., et al. Local effects of acute cellular injury on regional myocardial blood flow. J Clin Invest 57 (1976) 1359-1368
16. Hori M., Inoue M., Kitakaze M., et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol 250 3 Pt 2 (1986) H509-H518
17. Barcin C., Denktas A.E., Garratt K.N., et al. Relation of Thrombolysis In Myocardial Infarction (TIMI) frame count to coronary flow parameters. Am J Cardiol 91 (2003) 466-469